Trevi Therapeutics shares were up 72% at $4.27 after the company said it saw had a positive outcome from the planned sample size re-estimation for its ongoing Phase 2b trial in idiopathic pulmonary ...
Petrovax has announced positive results stemming from the Long-CoV-III-21 trial, which tested the efficacy of bovhyaluronidase azoximer (Longidaza) in patients with long-term COVID-19 pulmonary ...
The AIIMS Bhopal has achieved a significant milestone by successfully performing a rare and complex surgery to treat a 27-year-old patient diagnosed with Chronic Thromboembolic Pulmonary Artery ...
More than 11 million people in the United States are living with chronic obstructive pulmonary disease (COPD), including more than 3 million people with emphysema, a type of COPD. This chronic lung ...